UROV

Urovant Sciences Ltd.
UROV

Overview Fund Activity
Delisted

UROV was delisted on the 26th of March, 2021.

Back to rankings

27 hedge funds and large institutions have $64.3M invested in Urovant Sciences Ltd. in 2019 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 2 increasing their positions, 8 reducing their positions, and 3 closing their positions.

Holders
27
Holders Change
+8
Holders Change %
+42.11%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
2
Reduced
8
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PA
1
Perceptive Advisors
New York
$21.3M
2
WCM
2
Wildcat Capital Management
New York
$2.08M
3
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$474K
4
LA
4
LVW Advisors
New York
$372K
5
Goldman Sachs
5
Goldman Sachs
New York
$172K

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$372K
2
EAM
2
Eventide Asset Management
Massachusetts
$0
3
PM
3
Prosight Management
Texas
$972K
4
SCM
4
Sio Capital Management
New York
$1.79M
5
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$9.23M
Name Market Value Shares Shares
Change 		Shares
Change %
PCM
26
Prelude Capital Management
New York
$2K 166 -134 -45%
Barclays
27
Barclays
United Kingdom
$1K 149 +149 New
EAM
28
Eventide Asset Management
Massachusetts
– – -401,558 Closed
AAMU
29
Amundi Asset Management US
Massachusetts
– – -16,186 Closed
TRCT
30
Tower Research Capital (TRC)
New York
– – -914 Closed
CFGS
31
Concourse Financial Group Securities
Alabama
– – – –
1
2